SCHEMBL24944750

SCHEMBL24944750

CNc1nc(Nc2ccc(CN(C)C)cc2)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.41
▸ LCK P06239 2/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ BTK Q06187 2/20 0.41
▸ CDK2 P24941 2/20 0.35
▸ CAMK2D Q13557 1/20 0.35
▸ CCNA2 P20248 1/20 0.35
▸ CCNA1 P78396 1/20 0.35
▸ EML4 Q9HC35 5/20 0.33
▸ ALK Q9UM73 5/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ RET P07949 1/20 0.32
▸ ROS1 P08922 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ IKBKE Q14164 1/20 0.32
▸ TBK1 Q9UHD2 1/20 0.32
▸ BPTF Q12830 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205575 1.00 EGFR (0.41) EGFRLCKJAK3BTKCDK2
Formic Acid SCHEMBL30206333 0.97 EGFR (0.39) EGFRLCKJAK3BTKCDK2
SCHEMBL24944404 0.88 SYK (0.34) EGFRLCKJAK3BTKCDK2
SCHEMBL29173296 0.88 EML4 (0.33) EML4ALKPDE4BRETROS1
SCHEMBL24944178 0.87 BTK (0.43) EGFRLCKJAK3BTKCDK2
SCHEMBL24943828 0.87 CDK2 (0.37) LCKJAK3BTKCDK2CCNA2
SCHEMBL30206306 0.86 EML4 (0.33) EML4ALKRETROS1FLT3
SCHEMBL24944172 0.86 TBK1 (0.39) BTKEML4ALKPDE4BRET
SCHEMBL24943840 0.85 IKBKE (0.46) CDK2CCNA2CCNA1EML4ALK
SCHEMBL30205589 0.85 IKBKE (0.46) CDK2CCNA2CCNA1EML4ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN claimed
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback